Sarah Y. Zheng, AB; Rita F. Redberg, MD
Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M13-2931.
Requests for Single Reprints: Rita F. Redberg, MD, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0124.
Current Author Addresses: Ms. Zheng and Dr. Redberg: University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0124.
Author Contributions: Conception and design: S.Y. Zheng, R.F. Redberg.
Analysis and interpretation of the data: S.Y. Zheng.
Drafting of the article: S.Y. Zheng.
Critical revision of the article for important intellectual content: R.F. Redberg.
Final approval of the article: R.F. Redberg.
Administrative, technical, or logistic support: R.F. Redberg.
Collection and assembly of data: S.Y. Zheng, R.F. Redberg.
Sarah Y. Zheng, Rita F. Redberg. Premarket Approval Supplement Pathway: Do We Know What We Are Getting?. Ann Intern Med. 2014;160:798–799. doi: 10.7326/M13-2931
Download citation file:
Published: Ann Intern Med. 2014;160(11):798-799.
Cardiology, Healthcare Delivery and Policy, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use